Schonfeld Strategic Advisors’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-655,885	Closed	-$1.12M	–	2283
2024 Q3	$1.12M	Buy	+655,885	New	+$1.08M	0.01%	1126
2024 Q2	–	Sell	-268,245	Closed	-$1.01M	–	2459
2024 Q1	$1.01M	Buy	268,245 +116,869	+77%	+$684K	0.01%	1224
2023 Q4	$1.48M	Sell	151,376 -129,124	-46%	-$1.06M	0.01%	904
2023 Q3	$2.34M	Sell	280,500 -96,800	-26%	-$1.11M	0.02%	777
2023 Q2	$5.02M	Buy	377,300 +165,962	+79%	+$2.02M	0.04%	486
2023 Q1	$2.45M	Buy	211,338 +156,638	+286%	+$1.56M	0.02%	636
2022 Q4	$447K	Sell	54,700 -32,425	-37%	-$279K	﹤0.01%	1590
2022 Q3	$505K	Buy	+87,125	New	+$500K	﹤0.01%	1734
2020 Q1	–	Sell	-280,960	Closed	-$1.45M	–	1419
2019 Q4	$1.45M	Buy	+280,960	New	+$1.43M	0.04%	405
2017 Q1	–	Sell	-10,000	Closed	-$38K	–	697
2016 Q4	$38K	Buy	+10,000	New	+$72.7K	﹤0.01%	527
2016 Q3	–	Sell	-41,859	Closed	-$295K	–	505
2016 Q2	$295K	Buy	41,859 +31,859	+319%	+$291K	0.07%	318
2016 Q1	$85K	Buy	+10,000	New	+$98.3K	0.03%	289